MASHINIi

OrthoPediatrics Corp..

KIDS.US | Manufacture of medical and dental instruments and supplies

OrthoPediatrics Corp. is a medical device company focused exclusively on advancing the field of pediatric orthopedics. The company designs, develops, and markets implants and instruments used in the surgical treatment of orthopedic conditions in children. Their product portfolio includes systems for...Show More

Ethical Profile

Mixed.

OrthoPediatrics Corp. presents a mixed ethical profile. The company has positively impacted over 630,000 children globally with specialized orthopedic devices, serving 138,000 in 2024, and contributed $614,000 to charity in 2022. However, a 2020 recall of their Thoracolumbosacral pedicle screw system occurred due to incorrect laser etching. Reports also suggest significant data security vulnerabilities within related entities. A January 2025 breach at Central Texas Pediatric Orthopedics impacted 140,000 individuals, compromising sensitive data. Multiple other related entities also experienced breaches. Transparency is also lacking on fair pay, ethical sourcing, and environmental impact.

Value Scores

Better Health for All-20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect20
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-20
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-20
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech10
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

-20

OrthoPediatrics Corp. is exclusively focused on advancing pediatric orthopedics, with its products delivering substantial health benefits to children. The company's entire portfolio is dedicated to treating orthopedic conditions in children, having helped over 1.14 million children since inception, including approximately 138,000 in 2024

1
and nearly 39,000 in Q1 2025.
2
There is no evidence of the company generating revenue from products with negative health impacts. The company reported zero fatalities and zero OSHA work-related accidents from 2020 to 2022.
3
However, it had 5 recalls in the past three years (3 in 2020, 2 in 2022),
4
including one for a pedicle screw system that could lead to unintended fracture
5
and another for an attachment bolt that could cause surgical delays.
6
The company's ESG report mentions a focus on providing access to world-class technologies for underserved pediatric orthopedic patients, but specific details on the reach to vulnerable populations are limited.
7
The company supported 43 charity organizations in 2022 with $614,000,
8
which represents 0.3% of its 2024 revenue of $204.7 million.
9
Research and Development expenses were $2.4 million in Q1 2025, representing 4.58% of its $52.4 million revenue for that quarter.
10

Fair Money & Economic Opportunity

0

No evidence available to assess OrthoPediatrics Corp. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

20

For the 2024 fiscal year, the CEO-to-median employee pay ratio was 28:1.

1
The CEO's total compensation was $3,656,888, while the median employee's total compensation was $130,500.
2

Fair Trade & Ethical Sourcing

0

The provided articles do not contain specific, quantitative data points for any of the KPIs under the 'Fair Trade & Ethical Sourcing' value. While some articles mention internal policies, compliance with anti-corruption laws, and requirements for suppliers to be ISO 13485 certified

1
or to confirm no child labor,
2
these statements do not provide the necessary percentages, frequencies, or incident counts to score against the rubric's quantitative thresholds for fair trade certification, audit frequency, forced/child labor incidents, traceability coverage, remediation speed, ethical clause coverage, materials risk index, or supplier diversity spend.

Honest & Fair Business

-20

The company reported zero losses from legal cases related to bribery/corruption and false marketing for 2020-2022, and no proceedings resulted in fines over $25,000.

1
It has a whistleblower policy stating employees can report violations without fear of retaliation, and retaliation will not be tolerated, supported by a 24/7 compliance hotline.
2
However, the policy's communication to all staff or specific investigation timelines are not detailed. A restatement of certain financial reports for Symmetry (a related entity) and an SEC inquiry occurred in 2012, which is outside the five-year window for this KPI, but the company's financial reports are made available on its investor relations website.
3
The company's internal quality management group conducts comprehensive on-site inspection audits of its suppliers, and all device contract manufacturers are required to be ISO 13485 certified and FDA registered.
4
The company reported zero bribery/corruption controversies for 2020-2022.
5
The board's independent percentage was 55% for 2021 and 2022.
6
The company has an Anti-Corruption Policy, a Code of Ethics and Business Conduct Policy, and policies for complying with AdvaMed's Code of Ethics, available in multiple languages, and conducts annual training on AdvaMed Guidelines for employees, distributors, and agents.
7

Kind to Animals

0

No specific, concrete data points were found in the provided articles to assess KIDS.US against any of the 'Kind to Animals' KPIs. The articles discuss general ethical considerations in the medical field regarding animal-derived constituents, animal welfare standards in the food supply chain, and general information about cruelty-free companies, but none provide specific metrics, policies, or actions directly attributable to KIDS.US.

No War, No Weapons

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to the 'No War, No Weapons' ethical value. The articles primarily focus on corporate governance, financial details, and charitable contributions to pediatric orthopedic care, without addressing any involvement in arms manufacturing, military contracts, dual-use technologies, or related ethical policies or commitments.

1

Planet-Friendly Business

-20

The company reported no regulatory actions, violations, fines, or compliance issues.

1
An enhanced recycling program was implemented in Warsaw, Indiana, and a carbon reduction plan was created by the team in the United Kingdom.
2
The company is certified according to ISO 13485.
3
Scope 1 and Scope 2 emissions were 179 tons in 2020.
4
An internal ESG team was created in 2022, reporting to the Board’s Governance Committee, and an ESG Annual Report was published in 2022.
5
The company started reporting carbon emissions in 2023 and expects to increase ESG disclosures in future SEC filings.
6

Respect for Cultures & Communities

0

No evidence available to assess OrthoPediatrics Corp. on Respect for Cultures & Communities.

Safe & Smart Tech

10

The company has not experienced any material cybersecurity threats or incidents, including previous cybersecurity incidents, that have materially affected its business strategy, results of operations, or financial condition, as reported in February 2026.

1
Its cybersecurity program is aligned with the NIST Cybersecurity Framework and includes annual risk assessments, regular vulnerability scans, and penetration tests.
2
The company states it is certified according to ISO 13485 and complies with applicable regulations, including HIPAA and GDPR.
3
Its privacy policy, last updated March 8, 2021, outlines user rights for data access, rectification, erasure, and portability, and states data retention is limited to 6 months, except for legal reasons.
4
However, specific details on the effectiveness of security training, encryption implementation, or the scope of security testing are not provided. There is no information regarding AI ethics, audit practices, or algorithmic transparency.

Zero Waste & Sustainable Products

0

No evidence available to assess OrthoPediatrics Corp. on Zero Waste & Sustainable Products.

Own OrthoPediatrics Corp.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.